RICHARD BREWINGTON: Open Payments
NPI 1558483511 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 41 payments from 5 companies in 2025. Trend: 2023 $694 · 2024 $722 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 24 | $446 |
| Otsuka America Pharmaceutical, Inc. | 8 | $139 |
| Teva Pharmaceuticals USA, Inc. | 5 | $98 |
| Alkermes, Inc. | 2 | $60 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
Products named: COBENFY, ABILIFY ASIMTUFII, UZEDY, ARISTADA, FANAPT, ABILIFY MAINTENA.
Industry payments across MO — which companies pay providers there.
